Zum Hauptinhalt springen

The role of L-arginine in the pathogenesis of essential arterial hypertension ; L-аргинин и артериальная гипертензия: клинико-патогенетические взаимосвязи и коморбидность

Shcherbak, V. A. ; Medvedeva, A. S. ; et al.
In: Acta Biomedica Scientifica; Том 9, № 1 (2024); 32-41, 2024
Online academicJournal

Titel:
The role of L-arginine in the pathogenesis of essential arterial hypertension ; L-аргинин и артериальная гипертензия: клинико-патогенетические взаимосвязи и коморбидность
Autor/in / Beteiligte Person: Shcherbak, V. A. ; Medvedeva, A. S. ; Aksenova, T. A. ; Shcherbak, N. M. ; Aksenov, K. O. ; Щербак, В. А. ; Медведева, А. С. ; Аксенова, Т. А. ; Щербак, Н. М. ; Аксенов, К. О.
Link:
Zeitschrift: Acta Biomedica Scientifica; Том 9, № 1 (2024); 32-41, 2024
Veröffentlichung: Scientific Centre for Family Health and Human Reproduction Problems, 2024
Medientyp: academicJournal
DOI: 10.29413/ABS.2024-9.1.4
Schlagwort:
  • коморбидность
  • arginine
  • symmetrical dimethylarginine
  • asymmetrical dimethylarginine
  • citrulline
  • nitric oxide
  • nitric oxide synthase
  • comorbidity
  • аргинин
  • симметричный диметиларгинин
  • асимметричный диметиларгинин
  • цитруллин
  • оксид азота
  • синтаза оксида азота
Sonstiges:
  • Nachgewiesen in: BASE
  • Sprachen: Russian
  • Collection: Acta Biomedica Scientifica
  • Document Type: article in journal/newspaper
  • File Description: application/pdf
  • Language: Russian
  • Relation: https://www.actabiomedica.ru/jour/article/view/4596/2730; Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 25(3): 3786. doi:10.15829/1560-4071-2020-3-3786; Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: An individual participant-level data meta-analysis. Lancet. 2021; 397(10285): 1625-1636. doi:10.1016/S0140-6736(21)00590-0; Большакова О.В., Пушкарёв Б.С., Покоева З.А., Витковский Ю.А. Роль генетического полиморфизма кальциевых ионных каналов RYR2, CACNA1H, CACNA1C в развитии гипертрофии миокарда левого желудочка у больных эссенциальной гипертензией. Забайкальский медицинский вестник. 2022; 3: 9-17. doi:10.52485/19986173_2022_3_9; Maaliki D, Itani MM, Itani HA. Pathophysiology and genetics of salt-sensitive hypertension. Front Physiol. 2022; 13: 1001434. doi:10.3389/fphys.2022.1001434; Kurtz TW, Pravenec M, DiCarlo SE. Mechanism-based strategies to prevent salt sensitivity and salt-induced hypertension. Clin Sci (Lond). 2022; 136(8): 599-620. doi:10.1042/CS20210566; Zhong HJ, Zeng HL, Cai YL, Zhuang YP, Liou YL, Wu Q, et al. Washed microbiota transplantation lowers blood pressure in patients with hypertension. Front Cell Infect Microbiol. 2021; 11: 679624. doi:10.3389/fcimb.2021.679624; Verhaar BJH, Prodan A, Nieuwdorp M, Muller M. Gut microbiota in hypertension and atherosclerosis: A review. Nutrients. 2020; 12(10): 2982. doi:10.3390/nu12102982; Tain YL, Hsu CN. Hypertension of developmental origins: Consideration of gut microbiome in animal models. Biomedicines. 2022; 10(4): 875. doi:10.3390/biomedicines10040875; Guccione E, Richard S. The regulation, functions and clinical relevance of arginine methylation. Nat Rev Mol Cell Biol. 2019; 20(10): 642-657. doi:10.1038/s41580-019-0155-x; Tilvawala R, Thompson PR. Peptidyl arginine deiminases: Detection and functional analysis of protein citrullination. Curr Opin Struct Biol. 2019; 59: 205-215. doi:10.1016/j.sbi.2019.01.024; Гончаров Н.П. Оксид азота (NO): физиология и метаболизм (лекция). Андрология и генитальная хирургия. 2020; 21(3): 75-79. doi:10.17650/2070-9781-2020-21-3-75-79; Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM. Oxidative stress and hypertension. Circ Res. 2021; 128(7): 993-1020. doi:10.1161/CIRCRESAHA.121.318063; Чеботарёва А.А., Комаревцева И.А., Юсуф Р.М.С., Черных Ю.А., Вишницкая И.А., Комаревцева Е.В., и др. Метаболиты оксида азота в тканях, сыворотке крови, мононуклеарных и мезенхимальных стволовых клетках. Курский научно-практический вестник «Человек и его здоровье». 2016; 2: 90-95. doi:10.21626/vestnik/2016-2/17; Burov ON, Kletskii ME, Kurbatov SV, Lisovin AV, Fedik NS. Mechanisms of nitric oxide generation in living systems. Nitric Oxide. 2022; 118: 1-16. doi:10.1016/j.niox.2021.10.003; Rajapakse NW, Giam B, Kuruppu S, Head GA, Kaye DM. Impaired L-arginine-nitric oxide pathway contributes to the pathogenesis of resistant hypertension. Clin Sci (Lond). 2019; 133(20): 2061-2067. doi:10.1042/CS20190851; Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V. Arginine and endothelial function. Biomedicines. 2020; 8(8): 277. doi:10.3390/biomedicines8080277; Wu G, Meininger CJ, McNeal CJ, Bazer FW, Rhoads JM. Role of L-arginine in nitric oxide synthesis and health in humans. Adv Exp Med Biol. 2021; 1332: 167-187. doi:10.1007/978-3-030-74180-8_10; Gawrys J, Gajecki D, Szahidewicz-Krupska E, Doroszko A. Intraplatelet L-arginine-nitric oxide metabolic pathway: From discovery to clinical implications in prevention and treatment of cardiovascular disorders. Oxid Med Cell Longev. 2020; 2020: 1015908. doi:10.1155/2020/1015908; Куркин Д.В., Абросимова Е.Е., Бакулин Д.А., Ковалев Н.С., Дубровина М.А., Борисов А.В., и др. Модуляция активности различных синтаз оксида азота в качестве подхода к терапии эндотелиальной дисфункции. Фармация и фармакология. 2022; 10(2): 130-153. doi:10.19163/2307-9266-2022-10-2-130-153; Lundberg JO, Weitzberg E. Nitric oxide signaling in health and disease. Cell. 2022; 185(16): 2853-2878. doi:10.1016/j.cell.2022.06.010; Ambrosino P, Bachetti T, D’Anna SE, Galloway B, Bianco A, D’Agnano V. Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension. J Cardiovasc Dev Dis. 2022; 9(5): 136. doi:10.3390/jcdd9050136; Poredos P, Poredos AV, Gregoric I. Endothelial dysfunction and its clinical implications. Angiology. 2021; 72(7): 604-615. doi:10.1177/0003319720987752; Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: From mechanism to pharmacotherapies. Pharmacol Rev. 2021; 73(3): 924-967. doi:10.1124/pharmrev.120.000096; Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020; 9: 1417. doi:10.3390/jcm9051417; Mosleh W, Chen K, Pfau SE, Vashist A. Endotheliitis and endothelial dysfunction in patients with COVID-19: It’s role in thrombosis and adverse outcomes. J Clin Med. 2020; 9: 1862. doi:10.3390/jcm9061862; Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020; 24: 353. doi:10.1186/s13054-020-03062-7; Adebayo A, Varzideh F, Wilson S, Gambardella J, Eacobacci M, Jankauskas SS, et al. L-arginine and COVID-19: An update. Nutrients. 2021; 13(11): 3951. doi:10.3390/nu13113951; Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022; 20(5): 270-284. doi:10.1038/s41579-022-00713-0; Andrianto, Al-Farabi MJ, Nugraha RA, Marsudi BA, Azmi Y. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. Microvasc Res. 2021; 138: 104224. doi:10.1016/j.mvr.2021.104224; Ergül E, Yılmaz AS, Öğütveren MM, Emlek N, Kostakoğlu U, Çetin M. COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation. Int J Cardiovasc Imaging. 2022; 38(1): 25-32. doi:10.1007/s10554-021-02356-3; Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE. COVID-19 and L-arginine supplementations: Yet to find the missed key. Curr Protein Pept Sci. 2022; 23(3): 166-169. doi:10.2174/1389203723666220512104039; Kakabadze K, Megreladze I, Khvichia N, Mitagvaria N, Kipiani N, Dumbadze M, et al. Some aspects of role of nitric oxide in the mechanisms of hypertension (experimental study). Cardiol Res. 2021; 12(1): 16-24. doi:10.14740/cr1172; Meirelles CM, Matsuura C, Silva RS Jr, Guimaraes FF, Gomes PSC. Acute effects of L-arginine supplementation on oxygen consumption kinetics and muscle oxyhemoglobin and deoxyhemoglobin during treadmill running in male adults. Int J Exerc Sci. 2019; 12: 444-455.; Esen O, Eser MC, Abdioglu M, Benesova D, Gabrys T, Karayigit R. Eight days of L-citrulline or L-arginine supplementation did not improve 200-m and 100-m swimming time trials. Int J Environ Res Public Health. 2022; 19(8): 4462. doi:10.3390/ijerph19084462; Macuh M, Knap B. Effects of nitrate supplementation on exercise performance in humans: A narrative review. Nutrients. 2021; 13(9): 3183. doi:10.3390/nu13093183; Hlinský T, Gonzalez AM, Trexler ET. Effects of citrulline supplementation on exercise performance in humans: A review of the current literature. J Strength Cond Res. 2020; 34(5): 1480-1495. doi:10.1519/JSC.0000000000003426; San Juan AF, Dominguez R, Lago-Rodríguez Á, Montoya JJ, Tan R, Bailey SJ. Effects of dietary nitrate supplementation on weightlifting exercise performance in healthy adults: A systematic review. Nutrients. 2020; 12(8): 2227. doi:10.3390/nu12082227; Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): The ADMA, SDMA and hArg paradoxes. Cardiovasc Diabetol. 2018; 17(1): 1. doi:10.1186/s12933-017-0656-x; Keller A, Becker C, Nienhaus K, Beck K, Vincent A, Sutter R, et al. Arginine and arginine/ADMA ratio predict 90-day mortality in patients with out-of-hospital cardiac arrest-results from the prospective, observational COMMUNICATE trial. J Clin Med. 2020; 9(12): 3815. doi:10.3390/jcm9123815; Tain YL, Hsu CN. Toxic dimethylarginines: Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Toxins (Basel). 2017; 9(3): 92. doi:10.3390/toxins9030092; Стафеев А.Н., Логвиненко Н.И., Терешков П.П., Мельник А.В., Астраков С.В. Бронхиальная астма и артериальная гипертензия. Совместный вклад в развитие эндотелиальной дисфункции, связанной с дефицитом синтеза оксида азота. Сибирский медицинский вестник. 2020; (1): 3-7.; Ibrahim MA, Eraqi MM, Alfaiz FA. Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats. Heliyon. 2020; 6(1): e03209. doi:10.1016/j.heliyon.2020.e03209; Dovinová I, Hrabárová E, Jansen E, Kvandová M, Majzúnová M, Berenyiová A, et al. ADMA, homocysteine and redox status improvement affected by 7-nitroindazole in spontaneously hypertensive rats. Biomed Pharmacother. 2018; 106: 1478-1483. doi:10.1016/j.biopha.2018.07.096; Каладзе Н.Н., Янина Т.Ю., Ревенко Н.А. Роль асимметричного диметиларгинина в патогенезе артериальной гипертензии у детей. Здоровье ребенка. 2013; (5): 77-80.; Kołakowska U, Kuroczycka-Saniutycz E, Olański W, Wasilewska A. Correlation of salusin beta with hs-CRP and ADMA in hypertensive children and adolescents. Curr Pharm Des. 2018; 24(30): 3551-3557. doi:10.2174/1381612824666180607124531; Matjuda EN, Engwa GA, Letswalo PB, Mungamba MM, Sewani-Rusike CR, Nkeh-Chungag BN. Association of hypertension and obesity with risk factors of cardiovascular diseases in children aged 6–9 years old in the Eastern Cape province of South Africa. Children (Basel). 2020; 7(4): 25. doi:10.3390/children7040025; Подзолков В.И., Сафронова Т.А., Наткина Д.У. Эндотелиальная дисфункция у больных с контролируемой и неконтролируемой артериальной гипертензией. Терапевтический архив. 2019; 91(9): 108-114. doi:10.26442/00403660.2019.09.000344; Mangoni AA, Rodionov RN, McEvoy M, Zinellu A, Carru C, Sotgia S. New horizons in arginine metabolism, ageing and chronic disease states. Age Ageing. 2019; 48(6): 776-782. doi:10.1093/ageing/afz083; Rodrigues-Krause J, Krause M, Rocha IMGD, Umpierre D, Fayh APT. Association of L-arginine supplementation with markers of endothelial function in patients with cardiovascular or metabolic disorders: A systematic review and meta-analysis. Nutrients. 2018; 20; 11(1): 15. doi:10.3390/nu11010015; Maccallini C, Amoroso R. Preface to nitric oxide modulators in health and disease I. Molecules. 2022; 12; 27(20): 6820. doi:10.3390/molecules27206820; Khalaf D, Krüger M, Wehland M, Infanger M, Grimm D. The effects of oral L-arginine and L-citrulline supplementation on blood pressure. Nutrients. 2019; 11(7): 1679. doi:10.3390/nu11071679; Fender AC, Dobrev D. Nitric oxide as a fragile switch between cardioprotection and cardiac injury. Int J Cardiol. 2021; 343: 102-103. doi:10.1016/j.ijcard.2021.09.001; Kim A, Knudsen JG, Madara JC, Benrick A, Hill TG, Abdul Kadir L. Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes. Elife. 2021; 7(10): e72919. doi:10.7554/eLife.72919; Khan AA, Thomas GN, Lip GYH, Shantsila A. Endothelial function in patients with atrial fibrillation. Ann Med. 2020; 52(1-2): 1-11. doi:10.1080/07853890.2019.1711158; Maio R, Perticone M, Suraci E, Sciacqua A, Sesti G, Perticone F. Endothelial dysfunction and C-reactive protein predict the incidence of heart failure in hypertensive patients. ESC Heart Fail. 2021; 8(1): 399-407. doi:10.1002/ehf2.13088; Csipo T, Cassidy BR, Balasubramanian P, Drevets DA, Ungvari ZI, Yabluchanskiy A. Endothelial dysfunction and impaired neurovascular coupling responses precede cognitive impairment in a mouse model of geriatric sepsis. Front Aging Neurosci. 2021; 13: 644733. doi:10.3389/fnagi.2021.644733; Tian DS, Qin C, Zhou LQ, Yang S, Chen M, Xiao J, et al. FSAP aggravated endothelial dysfunction and neurological deficits in acute ischemic stroke due to large vessel occlusion. Signal Transduct Target Ther. 2022; 7(1): 6. doi:10.1038/s41392-021-00802-1; Yao Y, Song Q, Hu C, Da X, Yu Y, He Z, et al. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes. Cardiovasc Res. 2022; 118(1): 196-211. doi:10.1093/cvr/cvab013; De Leonardis F, Colalillo G, Finazzi Agrò E, Miano R, et al. Endothelial dysfunction, erectile deficit and cardiovascular disease: An overview of the pathogenetic links. Biomedicines. 2022; 10(8): 1848. doi:10.3390/biomedicines10081848; Zhang J. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases. Rev Cardiovasc Med. 2022; 23(2): 73. doi:10.31083/j.rcm2302073; Sandgren JA, Deng G, Linggonegoro DW, Scroggins SM, Perschbacher KJ, Nair AR, et al. Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice. JCI Insight. 2018; 3(19): e99403. doi:10.1172/jci.insight.99403; Giani JF, Janjulia T, Kamat N, Seth DM, Blackwell WL, Shah KH, et al. Renal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition. J Am Soc Nephrol. 2014; 25(12): 2752-2763. doi:10.1681/ASN.2013091030; Wu Z, Hou Y, Hu S, Bazer FW, Meininger CJ, McNeal CJ, et al. Catabolism and safety of supplemental L-arginine in animals. Amino Acids. 2016; 48(7): 1541-52. doi:10.1007/s00726-016-2245-9; Vianna LC, Fernandes IA, Barbosa TC, Amaral TG, Rocha NG, Secher NH, et al. Absent increase in vertebral artery blood flow during l-arginine infusion in hypertensive men. Am J Physiol Regul Integr Comp Physiol. 2018; 315(4): R820-R824. doi:10.1152/ajpregu.00088.2018; Shiraseb F, Asbaghi O, Bagheri R, Wong A, Figueroa A, Mirzaei K. Effect of L-arginine Supplementation on blood pressure in adults: A systematic review and dose-response meta-analysis of randomized clinical trials. Adv Nutr. 2022; 13(4): 1226-1242. doi:10.1093/advances/nmab155; Li H, Liu Q, Zou Z, Chen Q, Wang W, Baccarelli AA, et al. L-arginine supplementation to mitigate cardiovascular effects of walking outside in the context of traffic-related air pollution in participants with elevated blood pressure: A randomized, double-blind, placebo-controlled trial. Environ Int. 2021; 156: 106631. doi:10.1016/j.envint.2021.106631; Casonatto J, Cavalari JV. A single dosage of L-arginine oral supplementation induced post-aerobic exercise hypotension in hypertensive patients. J Diet Suppl. 2022; 29: 1-14. doi:10.1080/19390211.2022.2106006; Abukhodair AW, Abukhudair W, Alqarni MS. The effects of L-arginine in hypertensive patients: A literature review. Cureus. 2021; 13(12): e20485. doi:10.7759/cureus.20485; https://www.actabiomedica.ru/jour/article/view/4596
  • Rights: Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access).

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -